161 related articles for article (PubMed ID: 1570524)
1. [Chemotherapy of urologic metastases].
Zanoni F; Piva L; Milani A; Salvioni R; Faustini M; Nicolai N; Mangiarotti B; Pizzocaro G
Arch Ital Urol Nefrol Androl; 1992 Mar; 64(1):37-43. PubMed ID: 1570524
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of chemotherapy in urologic cancer].
Miki T; Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1349-57. PubMed ID: 2471457
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy of advanced genitourinary carcinoma with cis-diamminedichloroplatinum].
Uchida T; Kobayashi K; Arakawa T; Omata T; Li K; Ikeda S; Endo T; Ishibashi A; Koshiba K
Hinyokika Kiyo; 1984 Sep; 30(9):1173-83. PubMed ID: 6084421
[TBL] [Abstract][Full Text] [Related]
4. The role of chemotherapy in the management of malignant urogenital neoplasms.
Schnipper LE
Urol Clin North Am; 1976 Jun; 3(2):423-32. PubMed ID: 960317
[No Abstract] [Full Text] [Related]
5. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
7. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
8. The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.
Bokemeyer C; Harstrick A; Beyer J; Metzner B; Rüther U; Hartmann JT; Holstein K; Derigs HG; de Wit R; Casper J; Schöffski P; Kührer I; Illiger HJ; Kempf B; Reichle A; Föller A; Hossfeld DK; Fischer JT; Berdel WE; Gerhartz HH; Kirchner H; Pflüger KH; Ostermann H; Kanz L; Schmoll HJ
Semin Oncol; 1998 Apr; 25(2 Suppl 4):24-32; discussion 45-8. PubMed ID: 9578059
[TBL] [Abstract][Full Text] [Related]
9. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy and radiotherapy for urological cancer].
Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
[TBL] [Abstract][Full Text] [Related]
11. [The role of etoposide therapy in urogenital cancer].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 1996 Dec; 23(14):1929-35. PubMed ID: 8978800
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours.
Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J
Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
15. [Selection of treatment from a pathophysiological point of view. II: Studies on male urogenital tumors].
Koiso K; Kanoh S; Nemoto R; Ishikawa H; Ishikawa S; Ohtani M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):216-23. PubMed ID: 2418789
[TBL] [Abstract][Full Text] [Related]
16. High dose chemotherapy and stem cell support in the treatment of germ cell cancer.
Margolin K
J Urol; 2003 Apr; 169(4):1229-33. PubMed ID: 12629333
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
18. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
Fléchon A; Biron P; Philip I; Blay JY; Droz JP
Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
[TBL] [Abstract][Full Text] [Related]
19. The role of ifosfamide in the treatment of testicular and urothelial malignancies.
Roth BJ
Semin Oncol; 1996 Jun; 23(3 Suppl 7):19-27. PubMed ID: 8711497
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]